OUR PRODUCTS
Currently approved in Australia
COVID-19
Corona viruses are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome(MERS-CoV) and Severe Acute Respiratory Syndrome(SARS-CoV). World Health Organization(WHO) announced that the outbreak of corona virus disease(COVID-19) was first reported from Wuhan, China, on 31 December 2019.
Kodatef
(tafenoquine)
Kodatef is approved for malaria prevention (prophylaxis) when travelling to areas where malaria is present. For information regarding Kodatef, including the Therapeutic Goods Administration (TGA) approved Consumer Medical Information and Product Information (for health professionals only), please click the button below.